We had great success exhibiting Effer-K at the AAFP FMX (Family Medicine Experience) in Orlando, FL last month. Not only did we have the opportunity to discuss the significant benefits of prescribing Effer-K with the many physicians in attendance, we also had the pleasure of meeting the exhibitors for Medscape. According to the Medscape website, Medscape is the leading online global destination for physicians and healthcare professionals worldwide. They offer the latest medical news, expert perspectives, essential point-of-care drug and disease information, relevant professional education, and CME.1
Since Medscape was exhibiting at a nearby booth, we saw this as a great opportunity to discuss the mutual benefit of listing Effer-K in their database. Fortunately, Medscape agreed that their members should have access to information about Effer-K, and they wasted no time in adding Effer-K to their prescription drug list. (We learned Effer-K had been added to the potassium bicarbonate/potassium citrate monograph soon after we returned from Orlando.) Because we are confident Medscape members will find huge value in the addition of Effer-K to the database, we are excited Medscape recognized the value and chose to add Effer-K.
We are thrilled to be listed on Medscape!
It has only taken two years, countless emails and a few face-to-face meetings – but we are now happy to announce that Effer-K is listed in Epocrates! (We get it – they are busy…)
Epocrates is “the #1 medical reference app” used by more than “one million health care providers.” Almost any information pertaining to a prescription drug is available in the Epocrates database, including indications, dosing protocol and dangerous interactions. It’s popularity became increasingly apparent to us as we were frequently asked when meeting physicians, “why can’t I find you in Epocrates….” Well – now you can.
Thank you to the team at Epocrates who helped to get us listed.
At the recent AAFP show in Washington, DC, we met representatives from eMPR and learned more about their company. eMPR is a “prescribing Reference for drug monographs, the latest drug news, drug recalls, drug interactions as well as e-Prescribing.” Many physicians rely on information in eMPR to make daily prescribing decisions. But – unfortunately Effer-K was not listed in their database.
After talking to the staff, and sharing information about our product, they understood the benefits of Effer-K and listed it in their database. See: http://www.empr.com/effer-k/drug/34364/. We hope that this will make it much easier for physicians to get the information they need to write for Effer-K.